Switch to:
More From Other Websites
Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint? Feb 17 2017
Pacira Pharmaceuticals Announces Timing for 2016 Financial Results Webcast and Conference Call Feb 16 2017
Pacira Pharmaceuticals, Inc. to Present at the 2017 RBC Capital Markets’ Healthcare Conference Feb 15 2017
Implied Volatility Surging for Pacira Pharmaceuticals (PCRX) Stock Options Feb 14 2017
Biotech Premarket Movers: Pacira, Clearside Biomedical and Organovo Jan 25 2017
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jan 25 2017
Pacira Pharmaceuticals Announces Collaboration with DePuy Synthes to Support Promotion, Education... Jan 25 2017
DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc. Jan 25 2017
Friday’s 6 Biopharma Movers That Can’t Be Ignored Jan 06 2017
Pacira Pharmaceuticals Reports Preliminary 2016 Revenues of $276.4 Million Jan 06 2017
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 06 2017
Pacira Pharmaceuticals Reports Preliminary 2016 Revenues of $276.4 Million Jan 06 2017
Pacira Pharmaceuticals, Inc. to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 03 2017
Coverage initiated on Pacira Pharma by H.C. Wainwright Jan 03 2017
Innocoll stock slides 65% after FDA setback for pain treatment Dec 30 2016
The Year in U.S. Equity Funds: Resilient in a Tumultuous 2016 Dec 30 2016
Pacira Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PCRX) : December 27, 2016 Dec 27 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK